ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.

Morihiko Sagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.